Baylor Scott and White   Report issue

Academic/Hospital Phase 1 Phase 3 Phase 4
Founded: Dallas TX United States (1903)

Organization Overview

First Clinical Trial
2004
NCT00103766
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Baylor Scott and White | Baylor Scott and White Health | Baylor Scott and White Health Medical Center | Baylor Scott and White Institute for Rehabilitation | Baylor Scott and White Research Institute | Baylor Scott and White Research Institute-Trauma | Baylor Scott & White | O'Brien, Jeana D., MD, FACP, FCCP

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 4)

Pancreatic Diseases (Phase 3)

Pancreatic Neoplasms (Phase 3)

Urinary Incontinence, Stress (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 20